Could a Non-Prescription Antifungal Become a Major Advance for Multiple Sclerosis?

Dennis Bourdette, who chairs the department of neurology at Oregon State Health University and directs the university's Multiple Sclerosis and Neuroimmunology Center, puts it this way: All medications currently used to treat multiple sclerosis are anti-inflammatory. They control the abnormal immune response that attacks and destroys myelin in the brain and spinal cord.
http://ift.tt/1QbdZgp